The invention relates to a polypeptide
drug for preventing and treating Alzheimer's
disease, which can safely and effectively reduce the
protein level of PS1 in AD and inhibit
amyloid pathway
metabolism of
amyloid precursor
protein so as to improve
pathological deposition of beta
amyloid protein in AD. Through an endogenous PS1 protein polypeptide fragment, the effect that PS1 is used for inhibiting PS1 is realized, the specificity is high, the safety is good, the
curative effect is exact, the molecular weight is small, and under the help of a
cell-penetrating
peptide Tat sequence, the PS1 protein polypeptide fragment easily penetrates through a
blood brain barrier and smoothly reaches an AD susceptible region to play a role; besides, the compound is easy to synthesize and low in preparation cost, has obvious and unique advantages compared with
small molecule chemical inhibitors and
monoclonal antibody drugs, can become ideal drugs for preventing and treating AD, and has high clinical conversion value.